Stratagene Stock Tumbles, But the Index Remains Up | GenomeWeb

Returning from a two-week hiatus, the BCW Index gained 1.8 percent for the past three weeks Stratagene posted by far the biggest loss for both the past week and the three-week tracking period, after a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see related article).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.